Why the study?
Existing procedure bleeding risk classifications for periprocedural anticoagulant management are fragmented across specialties, inconsistent in methodology, and rarely extend beyond a few procedural domains, limiting their clinical applicability.
Provides a standardized, multidisciplinary consensus framework classifying procedure-specific bleeding risks across 24 surgical and interventional domains to guide individualized periprocedural anticoagulation management.
Standardizes periprocedural bleeding risk assessment to guide anticoagulation decisions; extends fragmented prior classifications with multidisciplinary consensus.
Periprocedural anticoagulant management requires balancing thrombotic risk against procedure-specific bleeding risk. Existing procedure bleeding risk classifications are fragmented across specialties, inconsistent in methodology, and rarely extend beyond a few procedural domains, limiting their clinical applicability. To develop a comprehensive, standardized, procedure-specific bleeding risk classification to accompany the 2026 GIHP-SFAR periprocedural anticoagulant management guidelines. A formal multidisciplinary consensus was conducted under the auspices of GIHP and SFAR, in collaboration with 24 surgical and interventional specialty societies. For each procedural domain, a working group performed a systematic literature review. Procedures were classified into four tiers: no bleeding risk, low bleeding risk, high bleeding risk, and very high bleeding risk. A specific category was created for procedures carrying particular contextual risk (e.g., anatomical site, patient factors, or need for reversible anticoagulation). Consensus was reached by the full expert panel. Twenty-four procedural domains were classified, ranging from regional anaesthesia and digestive endoscopy to cardiac surgery, neurosurgery, and ophthalmology. Each domain provides a procedure-specific bleeding risk table, with narrative supporting evidence. Procedures warranting delayed resumption of anticoagulation (≥72 hours) or use of short-acting/reversible anticoagulants are identified. The classification covers common and complex surgical scenarios, including those with limited published evidence where structured expert opinion was applied. This companion document provides clinicians with a standardized, evidence-based, procedure-specific bleeding risk framework across 24 domains to support individualized periprocedural anticoagulant decisions in daily practice.
No takes yet. Share an insight, caveat, or question.
Godiér et al. (2026) studied Periprocedural anticoagulant management. Procedure-specific bleeding risk classification was evaluated on Consensus classification of procedure-specific bleeding risk across procedural domains. A multidisciplinary expert consensus classified procedure-specific bleeding risk into 4 tiers across 24 procedural domains to guide periprocedural anticoagulant management.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: